Skip to Main Content

Author Details

Emmanuel Raffoux
Universite Paris Diderot
1998
211
58
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36376378Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO.Leukemia2023
37595275Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.Blood2023
36951151Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experience.Haematologica2023
37085611UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia.Leukemia2023
37403204Clinico-biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi-centric observational study.Br J Haematol2023
37433887Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID).Leukemia2023
36773040Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis.Ann Hematol2023
36736290Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia.Cell Stem Cell2023
36794507Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia <i>FLT3</i>-ITD patients.Haematologica2023
36890721Prognostic value of PET/CT and CT in T-cell lymphoblastic lymphoma/leukaemia patients: A retrospective cohort study of 145 patients.Br J Haematol2023
34895843Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy: A Prospective Observational Study From the Acute Leukaemia French Association (ALFA) Group.Clin Lymphoma Myeloma Leuk2022
35474100Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.Leukemia2022
35797337Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications.PLoS One2022
35750691A multiparametric niche-like drug screening platform in acute myeloid leukemia.Blood Cancer J2022
35355897Hepatosplenic Candidiasis in Patients With Hematological Malignancies: A 13-Year Retrospective Cohort Study.Open Forum Infect Dis2022
35654824Life expectancy and burden of late complications after reduced intensity conditioning allogeneic transplantation.Bone Marrow Transplant2022
36570694Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively.Hemasphere2022
36151081Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML.Blood Cancer J2022
32581253Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy.Leukemia2021
33881523Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study.Blood2021
33600210Eprenetapopt Plus Azacitidine in <i>TP53</i>-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM).J Clin Oncol2021
33570629Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort.Blood Adv2021
33596765Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia.Leuk Lymphoma2021
33564120Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia.Bone Marrow Transplant2021
33564086Correction to: Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality.Leukemia2021
34410352Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy.Blood2021
34785795Publisher Correction: Outcome of older (â¿¥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study.Leukemia2021
34625784Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML.Blood Adv2021
34301789Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy.Cancer Discov2021
34323164A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemia.Leuk Lymphoma2021
34047178Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study.Haematologica2021
33107983Phase 1 study to evaluate Crenigacestat (LY3039478) in combination with dexamethasone in patients with T-cell acute lymphoblastic leukemia and lymphoma.Cancer2021
33299234Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D-NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use.Haematologica2021
33153370Blinatumomabâ¿¿+â¿¿ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.Leuk Lymphoma2021
33043739Effects of azacitidine in 93 patients with <i>IDH1/2</i> mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study.Leuk Lymphoma2021
33119479Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia.J Clin Oncol2021
32871585A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia.Blood2021
31289201Mesenchymal stromal cells confer chemoresistance to myeloid leukemia blasts through Side Population functionality and ABC transporter activation.Haematologica2020
32081610Next-Generation Sequencing in Myeloid Neoplasm-Associated Sweet's Syndrome Demonstrates Clonal Relation between Malignant Cells and Skin-Infiltrating Neutrophils.J Invest Dermatol2020
31992840Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation.Leukemia2020
32076120Outcome of older (â¿¥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study.Leukemia2020
32100599Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy.Leuk Lymphoma2020
31710255Predictors and outcomes associated with hydroxyurea sensitivity in acute myeloid leukemia patients with high hyperleukocytosis.Leuk Lymphoma2020
31880804Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemia.Blood2020
32508181Ponatinib-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the real-life OPAL study.Leuk Lymphoma2020
32119970Should Transplantation Still Be Considered for Ph1-Negative Myeloproliferative Neoplasms in Transformation?Biol Blood Marrow Transplant2020
32380535Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results.Blood Adv2020
32132655Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study.Leukemia2020
30390009Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML.Leukemia2019
31905904Clofarabine Improves Relapse-Free Survival of Acute Myeloid Leukemia in Younger Adults with Micro-Complex Karyotype.Cancers (Basel)2019
  • 1 - 50 of 211

Recommended Authors

Leo Ruhnke
University Hospital Dresden
Career Start Year 2018
Number of shared co-authors 8
Curtis A Lachowiez
University of Texas MD Anderson Cancer Center
Career Start Year 2017
Number of shared co-authors 4
Justin M Watts
University of Miami, Sylvester Comprehensive Cancer Center
Career Start Year 2014
Number of shared co-authors 12
Patricia Kropf
Novant Health Cancer Institute - Elizabeth
Career Start Year 2009
Number of shared co-authors 7
Amanda Winters
University of Colorado School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Thomas K??hnke
Cancer Institute, Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Uma Borate
The Ohio State University
Career Start Year 2008
Number of shared co-authors 8
Felicitas Thol
Hannover Medical School
Career Start Year 2007
Number of shared co-authors 13
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 1
Marlise R Luskin
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 11
Tara L Lin
University of Kansas Medical Center
Career Start Year 2004
Number of shared co-authors 4
Daniel A Pollyea
University of Colorado Division of Hematology
Career Start Year 2004
Number of shared co-authors 12
Naseema Gangat
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 7
Ronan Swords
Oregon Health and Science University
Career Start Year 2004
Number of shared co-authors 9
Christopher S Hourigan
and Blood Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 9
Guillermo Garcia-Manero
MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 18
Bruno C Medeiros
AbbVie Inc.
Career Start Year 1996
Number of shared co-authors 9
Timothy S Pardee
Comprehensive Cancer Center of Wake Forest Baptist Health, Medical Center Boulevard
Career Start Year 1995
Number of shared co-authors 12
David A Rizzieri
Duke University Medical Center
Career Start Year 1995
Number of shared co-authors 18
Thoralf Lange
Hospital Weissenfels
Career Start Year 1994
Number of shared co-authors 6
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 2
Peter Westervelt
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 8
Michael Dworzak
St. Anna Children's Cancer Research Institute (CCRI)
Career Start Year 1990
Number of shared co-authors 5
Sima Jeha
St. Jude Children's Research Hospital
Career Start Year 1988
Number of shared co-authors 6
Clayton A Smith
University of Colorado, Aurora CO.
Career Start Year 1987
Number of shared co-authors 0
Robert H Collins
University of Texas Southwestern Medical Center
Career Start Year 1987
Number of shared co-authors 10
Dietger Niederwieser
University of Leipzig
Career Start Year 1982
Number of shared co-authors 14
Kenneth B Miller
Tufts Medical Center
Career Start Year 1981
Number of shared co-authors 3
John F DiPersio
Washington University School of Medicine
Career Start Year 1978
Number of shared co-authors 14
Robin Fo??
Sapienza University.
Career Start Year 1968
Number of shared co-authors 9

Collaborators

Herv?? Dombret
Institut de Recherche Saint-Louis, Universite de Paris
Co-authored papers 118
Lionel Ad??s
Assistance Publique des Hopitaux de Paris (AP-HP)
Co-authored papers 57
Claude Preudhomme
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Co-authored papers 38
Claude Gardin
Avicenne Hospital
Co-authored papers 32
Raphael Itzykson
Universite Paris Cite, INSERM, CNRS
Co-authored papers 30
Emmanuelle Clappier
Saint-Louis Hospital
Co-authored papers 18
Thorsten Braun
Centre Hospitalier Universitaire Hopital Avicenne
Co-authored papers 18
Thomas Cluzeau
Universite Nice Cote d'azur, CHU de Nice
Co-authored papers 16
Elie Azoulay
Paris Cite University
Co-authored papers 13
Jean Soulier
University of Paris
Co-authored papers 12
Alexandre Puissant
Universite de Paris, INSERM, CNRS
Co-authored papers 8
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Co-authored papers 8
Matthieu Duchmann
Assistance Publique-Hopitaux de Paris, Universite de Paris
Co-authored papers 7
Hugues de Th??
Universite Paris Cite, Inserm, CNRS, Institut de Recherche Saint-Louis
Co-authored papers 6
Cl??mentine Chauvel
Universite Paris Cite, INSERM, CNRS
Co-authored papers 4
Reinaldo Dal Bello
Universite Paris Cite, INSERM, CNRS
Co-authored papers 4
Jeannig Berrou
Universite Paris Cite, Institut de Recherche Saint-Louis
Co-authored papers 4
Christoph R??llig
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 3
Dominique Charron
Universite de Strasbourg
Co-authored papers 3
Anna Raimbault
CHU La Miletrie University Hospital Poitiers France.
Co-authored papers 3
Fabien Calvo
Universite de Paris-Cite
Co-authored papers 3
Justine Penneroux
Universite Paris Cite, INSERM, CNRS
Co-authored papers 3
Gaetano Sodaro
Universite Paris Cite, INSERM, CNRS
Co-authored papers 2
Hsin-Chieh Wu
Chaoyang University of Technology
Co-authored papers 2
Marie-H??l??ne Schlageter
Universite de Paris, U1 INSERM
Co-authored papers 2
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Daniel J DeAngelo
Dana-Farber Cancer Institute
Co-authored papers 2
Kimberly Stegmaier
Dana-Farber Cancer Institute
Co-authored papers 2
Lina Benajiba
Universite de Paris, Inserm CIC 1427
Co-authored papers 2
Nina Fenouille
Universite Paris Cite, INSERM, CNRS
Co-authored papers 2
Release 1.2